Evidence map›Paper›PMID 42523917›Full record

ArticleFrontiers in pharmacology2026

Neuroprotective potential of selenium nanoparticles and/or physical and mental activities against social isolation-induced depression in a rat model: inflammatory, oxidative stress, apoptotic, and neurotransmission modulatory pathways.

Karema Abu-Elfotuh, Furqan Hashim Hussein, Roaa Hameed Alwaidh, Qutaiba A Qasim, Layla A Al-Kharashi, Fatma M Mostafa, Enji Reda, Abdou Mohammed Ahmed Elsharkawy, Heba Abdelnaser Aboelsoud, Shaimaa R Abdelmohsen and 7 more

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Karema Abu-ElfotuhClinical Pharmacy Department, Faculty of Pharmacy (Girls), Al-Azhar University, Cairo, Egypt.
Furqan Hashim HusseinCollage of Dentistry, University of Alkafeel, Kufa, Iraq.
Roaa Hameed AlwaidhDepartment of Pathology and Forensic Medicine, Faculty of Medicine, University of Kufa, Kufa, Iraq.
Qutaiba A QasimDepartment of Clinical Laboratory Sciences, College of Pharmacy, University of Basrah, Basrah, Iraq.
Layla A Al-KharashiDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Fatma M MostafaMicrobiology Department, College of Pharmacy, Al-Ayen Iraqi University, AUIQ, An Nasiriyah, Iraq.
Enji RedaDepartment of Pharmacology & Toxicology, Faculty of Pharmacy, Sinai University - Kantara Branch, Ismailia, Egypt.
Abdou Mohammed Ahmed ElsharkawyAnatomy Department, Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
Heba Abdelnaser AboelsoudDepartment of Basic Medical Science, College of Medicine, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia.
Shaimaa R AbdelmohsenAnatomy and Embryology Department, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt.
Magy R KozmanClinical Pharmacy Department, Faculty of Pharmacy, Misr University for Science and Technology, Giza, Egypt.
Nervana Mostafa Kamal BayoumyPhysiology Department, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Yasmen F MahranDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt.
Abeer AltamimiNatural and Health Sciences Research Center, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
Khaled Ragab AbdelhakimDepartment of Histology, Misr University for Science and Technology, Giza, Egypt.
Ahmed M E HamdanDepartment of Pharmacy Practice, Faculty of Pharmacy, University of Tabuk, Tabuk, Saudi Arabia.
Aliaa Osman Abou-BeihDepartment of Clinical Pharmacy, Ain Shams University Specialized Hospital, Cairo, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Social isolation (SI), attributable to modern lifestyles and fast-growing technology, is a leading cause of depression. Selenium nanoparticles (Se-NPs) are neuroactive agents owing to their antioxidant and anti-inflammatory activities. Additionally, physical and mental activities (Ph&M) exert neuroprotective effects by optimizing the release of both neurotransmitters and growth factors. However, their neuroprotective effects against SI-induced depression are still poorly investigated. Aim: We aim to explore the neuroprotective effect of Se-NPs, Ph&M, and their combination to guard against the harmful effects of SI-induced depression in a rat model. Methods: Fifty Sprague Dawley rats were randomly allocated into five groups: control, SI, Ph&M, orally administered Se-NPs (0.1 mg/kg), and a combination group. Neuroprotective activity was quantitatively estimated pharmacologically, biochemically, histologically, and behaviorally. Results: SI caused behavioral and biochemical alteration in the rat model, decreasing neurotransmitter levels, increasing the transcription of inflammatory response genes ( Conclusion: Se-NPs and Ph&M, especially their combination, showed promising protective effects against neuroinflammation, oxidative stress, apoptosis and subsequent alterations of test animal behaviors precipitated by SI.

Indexed as

depressionmental activityphysical activityselenium nanoparticlessocial isolation

Identifiers

PMID42523917
PMCPMC13407994

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.